CRISPR 기술 시장 규모, 점유율, 성장 분석, 제품 유형별, 용도별, 지역별 - 산업 예측(2024-2031년)

Global CRISPR Technology Market size was valued at USD 3.0 billion in 2022 and is poised to grow from USD 3.50 billion in 2023 to USD 11.86 billion by 2031, growing at a CAGR of 16.50% during the forecast period (2024-2031).

The global CRISPR technology market is a rapidly developing and promising area within biotechnology. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, represents a revolutionary gene-editing tool that enables precise alterations to the DNA of living organisms. This innovative technology has captured significant interest due to its potential to address genetic disorders, drive advancements in therapeutic development, and transform agricultural practices. The CRISPR market has experienced notable growth and is projected to continue expanding in the near future. Several factors contribute to this growth, including the rising demand for personalized medicine, progress in gene therapy, and the increasing prevalence of genetic disorders. The integration of CRISPR technology into drug discovery, development, and diagnostic tool creation has further accelerated market expansion. Additionally, the industrial biotechnology sector is utilizing CRISPR for bioengineering and bio-manufacturing, enabling the creation of novel enzymes, biofuels, and specialty chemicals that offer sustainable alternatives to conventional manufacturing methods. Overall, the CRISPR technology market is evolving rapidly with the potential to revolutionize various fields, including healthcare, agriculture, and industrial biotechnology. Its applications hold promise for enhancing human health, improving food production, and advancing sustainable manufacturing practices. As research and development continue to progress, addressing ethical and regulatory concerns will be essential to ensure the responsible and beneficial use of CRISPR technology moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segmental Analysis

Global CRISPR Technology Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Products [CRISPR Libraries, CRISPR Kits & Enzymes, Other Products], Services [Cell Line Engineering, gRNA Design & Vector Consultation, Screening Services, Other Services]. Based on Application, the market is segmented into Biomedical, Industrial, Agricultural, and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global CRISPR Technology Market

Governments worldwide have significantly ramped up their funding and investment in CRISPR technology, creating a supportive environment for research and development. This increased financial backing has facilitated groundbreaking discoveries and accelerated advancements in the field, fostering a dynamic market for CRISPR innovations. As a result, the enhanced investment in CRISPR technology has led to a more vibrant and promising sector, driving progress and expanding opportunities within biotechnology. This support from government bodies is crucial for advancing research efforts and bringing transformative CRISPR-based solutions to fruition.

Restraints in the Global CRISPR Technology Market

The gene editing field faces significant technical challenges associated with CRISPR technology. Despite its considerable potential, several hurdles impede its broader application, including the complexity of achieving precise genome modifications, managing off-target effects, and ensuring effective delivery mechanisms. Addressing these technical issues is crucial for CRISPR technology to fulfill its transformative potential across various industries. Overcoming these obstacles will be key to unlocking the full benefits of CRISPR and advancing its use in a wide range of applications.

Market Trends of the Global CRISPR Technology Market

A notable trend in the CRISPR technology market is the growing integration of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are increasingly leveraging CRISPR to streamline the drug discovery process, enhance target identification and validation, and improve both preclinical and clinical studies. CRISPR-based screening platforms facilitate more efficient identification and validation of drug targets, which contributes to the development of more effective therapies. Furthermore, CRISPR enables the creation of advanced disease models and organoids, aiding in the study of disease mechanisms and the evaluation of potential drug candidates. In addition to its impact on drug discovery, CRISPR technology is also making strides in agriculture and food production, as well as in the development of CRISPR-based diagnostics. The emphasis on ethical and regulatory considerations is also growing, reflecting a broader awareness of the implications of CRISPR technology. These trends underscore the expanding potential of CRISPR across multiple industries, highlighting its transformative capabilities and the ongoing evolution of its applications.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

CRISPR Technology Market by Product Type

• Market Overview
• Products
  • CRISPR Libraries
  • CRISPR Kits & Enzymes
  • Other Products
• Services
  • Cell Line Engineering
  • gRNA Design & Vector Consultation
  • Screening Services
  • Other Services

CRISPR Technology Market by Application

• Market Overview
• Biomedical
• Industrial
• Agricultural
• Other Applications

CRISPR Technology Market by End-User

• Market Overview
• Pharma & Biopharma Companies
• Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

CRISPR Technology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (Danaher Corporation) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corp (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellecta Limited (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origene Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Base Genomics Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prime Medicine, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arbor Biotechnologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Excision BioTherapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments